First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies-Reference-Cited by-同舟云学术

First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies

Published:2021-02-16 Issue:4 Volume:39 Page:1047-1056
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Piha-Paul Sarina A.^ORCID,Thein Kyaw Z.,De Souza Paul,Kefford Richard,Gangadhar Tara,Smith Christopher,Schuster Shelly,Zamboni William C.,Dees Claire E.,Markman Ben

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-021-01081-x.pdf

Reference23 articles.

1. Herbst RS, Khuri FR (2003) Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat Rev 29(5):407–415

2. Aapro M (1996) The scientific rationale for developing taxoids. Anti-Cancer Drugs 7(Suppl 2):33–36

3. Montero A, Fossella F, Hortobagyi G, Valero V (2005) Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol 6(4):229–239. https://doi.org/10.1016/s1470-2045(05)70094-2

4. Saloustros E, Mavroudis D, Georgoulias V (2008) Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opin Pharmacother 9(15):2603–2616. https://doi.org/10.1517/14656566.9.15.2603

5. Kuppens IE (2006) Current state of the art of new tubulin inhibitors in the clinic. Curr Clin Pharmacol 1(1):57–70

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Nanotechnology and Phytochemicals in Anticancer Therapy;Pharmaceutics;2024-09-05

2. Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer;Current Drug Delivery;2024-06

3. pH-responsive self-assembled nanoparticles for tumor-targeted drug delivery;Journal of Drug Targeting;2024-05-09

4. Multifunctionality of cyclodextrin-based polymeric nanoparticulate delivery systems for chemotherapeutics, combination therapy, and theranostics;International Journal of Pharmaceutics;2024-04

5. Docetaxel-loaded nanoformulations delivery for breast cancer management: Challenges, recent advances, and future perspectives;Journal of Drug Delivery Science and Technology;2024-02